SpringWorks
![FDA Prolongates PDUFA Nirogacestat's NDA for desmoid tumors is three months from today](https://pharmtales.com/wp-content/uploads/2023/06/FDA-Prolongates-PDUFA-Nirogacestats-NDA-for-desmoid-tumors-is-three-months-from-today.jpg)
FDA Prolongates PDUFA Nirogacestat’s NDA for desmoid tumors is three months
SG Tylor
Source – SpringWorks According to SpringWorks Therapeutics on June 7, 2023, the FDA has extended the Prescription Drug User Fee ...
Source – SpringWorks According to SpringWorks Therapeutics on June 7, 2023, the FDA has extended the Prescription Drug User Fee ...